Page last updated: 2024-08-18
lactobionic acid and oxazolone
lactobionic acid has been researched along with oxazolone in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Crumrine, D; Elias, PM; Feingold, KR; Hatano, Y; Holleran, WM; Kim, EG; Man, MQ; Mauro, TM; Scharschmidt, TC; Uchida, Y | 1 |
Elias, PM; Fujiwara, S; Hatano, Y; Jeong, SK; Matsuda-Hirose, H; Sakai, T; Takahashi, D; Zhang, W | 1 |
Other Studies
2 other study(ies) available for lactobionic acid and oxazolone
Article | Year |
---|---|
Maintenance of an acidic stratum corneum prevents emergence of murine atopic dermatitis.
Topics: Acute Disease; Adjuvants, Immunologic; Administration, Topical; Animals; Antimicrobial Cationic Peptides; Dermatitis, Allergic Contact; Dermatitis, Atopic; Disaccharides; Epidermis; Female; Haptens; Hydrogen-Ion Concentration; Immunoglobulin E; Lipid Bilayers; Mice; Mice, Hairless; Oxazolone; Serine Endopeptidases; Th2 Cells | 2009 |
Combined Benefits of a PAR2 Inhibitor and Stratum Corneum Acidification for Murine Atopic Dermatitis.
Topics: Animals; Dermatitis, Atopic; Disaccharides; Disease Models, Animal; Drug Therapy, Combination; Epidermis; Immunoglobulins; Mice; Mice, Inbred Strains; Oxazolone; Random Allocation; Receptor, PAR-2; Receptors, Cytokine; Treatment Outcome | 2016 |